Omega-3-acid Ethyl Esters Patent Expiration

Omega-3-Acid Ethyl Esters is Used for managing lipid levels. It was first introduced by Woodward Pharma Services Llc in its drug Lovaza on Nov 10, 2004. 14 different companies have introduced drugs containing Omega-3-Acid Ethyl Esters.


Omega-3-acid Ethyl Esters Patents

Given below is the list of patents protecting Omega-3-acid Ethyl Esters, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lovaza US5502077 Fatty acid composition Mar 26, 2013

(Expired)

Woodward
Lovaza US5656667 Fatty acid composition Apr 10, 2017

(Expired)

Woodward
Lovaza US7732488 Pharmaceutical composition comprising low concentrations of environmental pollutants Jan 30, 2025 Woodward


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Omega-3-acid Ethyl Esters Generics

Several generic applications have been filed for Omega-3-Acid Ethyl Esters. The first generic version for Omega-3-Acid Ethyl Esters was by Glw Pharma Gmbh and was approved on Apr 7, 2014. And the latest generic version is by Slayback Pharma Llc and was approved on Dec 7, 2023.

Given below is the list of companies who have filed for Omega-3-acid Ethyl Esters generic.


1. PURACAP PHARM LLC

Puracap Pharmaceutical Llc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Puracap Pharm Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Jun 15, 2020


2. MANKIND PHARMA

Mankind Pharma Ltd has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Nov 15, 2021


3. CHARTWELL

Chartwell Life Molecules Llc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Aug 7, 2019


4. ZYDUS LIFESCIENCES

Zydus Lifesciences Global Fze has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Discontinued ORAL N/A Jun 14, 2019


5. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Sep 19, 2017


6. GLW

Glw Pharma Gmbh has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Glw.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Aug 19, 2020


7. CSPC-NBP PHARM

Cspc-nbp Pharmaceutical Co Ltd has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Cspc-nbp Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB May 12, 2020


8. SOFGEN PHARMS

Sofgen Pharmaceuticals Llc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Sofgen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Jul 10, 2019


9. SLAYBACK PHARMA LLC

Slayback Pharma Llc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Slayback Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Dec 7, 2023


10. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Feb 25, 2019


11. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Nov 27, 2015


12. APOTEX

Apotex Inc has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Sep 30, 2014


13. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Omega-3-acid Ethyl Esters. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS capsule Prescription ORAL AB Jan 9, 2020